Physician profile
Alison Moore
NPI 1427668136
$2,095.94
in general payments reported to CMS, 2019-2025
18 companies · $547 in 2025
The $547 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $28.70 · 2021: $105 · 2022: $352 · 2023: $411 · 2024: $652 · 2025: $547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,609.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $350.04 | 2020-2025 | Cequa |
| Oyster Point Pharma, INC. | $321.29 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Bausch & Lomb Americas INC. | $272.16 | 2022-2025 | Stellaris, Scoutpro Osmolarity System, Xiidra |
| Mallinckrodt Hospital Products INC. | $248.56 | 2023-2025 | Acthar |
| Alcon Vision LLC | $169.94 | 2024 | Argos |
| Harrow Eye, LLC | $163.83 | 2024-2025 | Vevye |
| Johnson & Johnson Vision Care, INC. | $155.08 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $73.98 | 2021-2023 | |
| Kala Pharmaceuticals, INC. | $73.51 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $64.94 | 2024 | Purified Cortrophin Gel |
| Abbvie INC. | $45.16 | 2022-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $34.57 | 2021 | |
| Dompe US, INC. | $25.90 | 2024 | Oxervate |
| Heidelberg Engineering, INC. | $24.78 | 2022 | |
| Thea Pharma INC. | $20.94 | 2024 | Iyuzeh |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $18.90 | 2024 | Tecnis Iol, Tecnis Iol, Tecnis Simplicity |
| Horizon Therapeutics Plc | $16.68 | 2022 | |
| Eyevance Pharmaceuticals LLC | $15.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.